Literature DB >> 24158346

The role of microRNAs in hepatitis C virus RNA replication.

K Dominik Conrad1, Michael Niepmann.   

Abstract

Replication of hepatitis C virus (HCV) RNA is influenced by a variety of microRNAs, with the main player being the liver-specific microRNA-122 (miR-122). Binding of miR-122 to two binding sites near the 5' end of the 5' untranslated region (UTR) of the HCV genomic RNA results in at least two different effects. On the one hand, binding of miR-122 and the resulting recruitment of protein complexes containing Argonaute (Ago) proteins appears to mask the viral RNA's 5' end and stabilizes the viral RNA against nucleolytic degradation. On the other hand, this interaction of miR-122 with the 5'-UTR also stimulates HCV RNA translation directed by the internal ribosome entry site (IRES) located downstream of the miR-122 binding sites. However, it is suspected that additional, yet undefined roles of miR-122 in HCV replication may also contribute to HCV propagation. Accordingly, miR-122 is considered to contribute to the liver tropism of the virus. Besides miR-122, let-7b, miR-196, miR-199a* and miR-448 have also been reported to interact directly with the HCV RNA. However, the latter microRNAs inhibit HCV replication, and it has been speculated that miR-199a* contributes indirectly to HCV tissue tropism, since it is mostly expressed in cells other than hepatocytes. Other microRNAs influence HCV replication indirectly. Some of those are advantageous for HCV propagation, while others suppress HCV replication. Consequently, HCV up-regulates or down-regulates, respectively, the expression of most of these miRNAs.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24158346     DOI: 10.1007/s00705-013-1883-4

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  25 in total

1.  Brief Report: Coordinated Modulation of Circulating miR-21 in HIV, HIV-Associated Pulmonary Arterial Hypertension, and HIV/Hepatitis C Virus Coinfection.

Authors:  Victoria N Parikh; Joseph Park; Ivana Nikolic; Richard Channick; Paul B Yu; Teresa De Marco; Priscilla Y Hsue; Stephen Y Chan
Journal:  J Acquir Immune Defic Syndr       Date:  2015-11-01       Impact factor: 3.731

Review 2.  Translation initiation of the HIV-1 mRNA.

Authors:  Théophile Ohlmann; Chloé Mengardi; Marcelo López-Lastra
Journal:  Translation (Austin)       Date:  2014-10-31

Review 3.  MicroRNA and hepatitis C virus--challenges in investigation and translation: a review of the literature.

Authors:  Paul Ravi Waldron; Mark Holodniy
Journal:  Diagn Microbiol Infect Dis       Date:  2014-06-05       Impact factor: 2.803

4.  MicroRNAs as Therapeutic Targets in Lung Disease: Prospects and Challenges.

Authors:  Tadashi Sato; Hario Baskoro; Stephen I Rennard; Kuniaki Seyama; Kazuhisa Takahashi
Journal:  Chronic Obstr Pulm Dis       Date:  2015-12-14

Review 5.  Host-Directed Antiviral Therapy.

Authors:  Naveen Kumar; Shalini Sharma; Ram Kumar; Bhupendra N Tripathi; Sanjay Barua; Hinh Ly; Barry T Rouse
Journal:  Clin Microbiol Rev       Date:  2020-05-13       Impact factor: 26.132

6.  Transcriptional suppression of miR-181c by hepatitis C virus enhances homeobox A1 expression.

Authors:  Anupam Mukherjee; Shubham Shrivastava; Joydip Bhanja Chowdhury; Ranjit Ray; Ratna B Ray
Journal:  J Virol       Date:  2014-04-30       Impact factor: 5.103

Review 7.  Murine models of hepatitis C: what can we look forward to?

Authors:  Markus von Schaewen; Alexander Ploss
Journal:  Antiviral Res       Date:  2014-01-24       Impact factor: 5.970

Review 8.  The role of microRNAs in hepatitis C virus replication and related liver diseases.

Authors:  Chang Ho Lee; Ji Hyun Kim; Seong-Wook Lee
Journal:  J Microbiol       Date:  2014-05-29       Impact factor: 3.422

9.  Dual Effects of Let-7b in the Early Stage of Hepatitis C Virus Infection.

Authors:  Yung-Ju Yeh; Ching-Ping Tseng; Sheng-Da Hsu; His-Yuan Huang; Michael M C Lai; Hsien-Da Huang; Ju-Chien Cheng
Journal:  J Virol       Date:  2021-01-28       Impact factor: 5.103

Review 10.  MicroRNAs involved in the lipid metabolism and their possible implications for atherosclerosis development and treatment.

Authors:  Jan Novák; Julie Bienertová-Vašků; Tomáš Kára; Miroslav Novák
Journal:  Mediators Inflamm       Date:  2014-04-24       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.